Patterns of dopamine transporter imaging in subtypes of multiple system atrophy

To investigate the differences in the pattern of striatal (caudate and putamen) dopamine transporter (DAT) loss in a multiple system atrophy (MSA) cohort, based on the clinical variants parkinsonian subtype (MSA‐P) and cerebellar subtype (MSA‐C) via (11)C‐N‐2‐carbomethoxy‐3‐(4‐fluorophenyl)‐tropane (11C‐CFT) positron emission tomography (PET) imaging.

[1]  V. Dhawan,et al.  Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study , 2002, Synapse.

[2]  Ke Yang,et al.  Considerations before initiating therapy in Parkinsonism: basing on the quality of life , 2019, Journal of Neurology.

[3]  K. Jellinger.  Neuropathology of multiple system atrophy: New thoughts about pathogenesis , 2014, Movement disorders : official journal of the Movement Disorder Society.

[4]  H U Rehman,et al.  Multiple system atrophy , 2001, Postgraduate medical journal.

[5]  M. Caron,et al.  The dopamine transporter: A crucial component regulating dopamine transmission , 1997, Movement disorders : official journal of the Movement Disorder Society.

[6]  Dae Hyuk Moon,et al.  Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy , 2012, The Journal of Nuclear Medicine.

[7]  C. Sohn,et al.  Differentiation of Parkinsonism-Predominant Multiple System Atrophy from Idiopathic Parkinson Disease Using 3T Susceptibility-Weighted MR Imaging, Focusing on Putaminal Change and Lesion Asymmetry , 2015, American Journal of Neuroradiology.

[8]  David J. Brooks,et al.  Molecular imaging of dopamine transporters , 2016, Ageing Research Reviews.

[9]  Yilong Ma,et al.  Preserved caudate function in young-onset patients with Parkinson’s disease: a dual-tracer PET imaging study , 2019, Therapeutic advances in neurological disorders.

[10]  Richard Watts,et al.  Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. , 2011, Brain : a journal of neurology.

[11]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[12]  J. Seibyl,et al.  [123I]β-CIT SPECT imaging assessment of the rate of Parkinson’s disease progression , 2001, Neurology.

[13]  Klaus Seppi,et al.  Grading of neuropathology in multiple system atrophy: Proposal for a novel scale , 2005, Movement disorders : official journal of the Movement Disorder Society.

[14]  L. Deecke,et al.  [123I]β‐CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration , 2000, Movement disorders : official journal of the Movement Disorder Society.

[15]  Qian Xu,et al.  A Fully Automatic Framework for Parkinson’s Disease Diagnosis by Multi-Modality Images , 2019, Front. Neurosci..

[16]  E. Tolosa,et al.  Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C) , 2011, Journal of Neurology.

[17]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[18]  J. Joutsa,et al.  No relevant midbrain atrophy in Parkinson's disease , 2016, Acta neurologica Scandinavica.

[19]  J. Seibyl,et al.  [123I]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression. , 2001, Neurology.

[20]  J. Holton,et al.  The neuropathology, pathophysiology and genetics of multiple system atrophy , 2012, Neuropathology and applied neurobiology.

[21]  P. Bauer,et al.  Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson’s disease , 2007, Journal of Neural Transmission.

[22]  T. Lynch,et al.  Normal dopamine transporter imaging does not exclude multiple system atrophy. , 2014, Parkinsonism & related disorders.

[23]  Stanley Fahn,et al.  Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes , 2010, Journal of Nuclear Medicine.

[24]  Jian Wang,et al.  Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study. , 2015, Parkinsonism & related disorders.

[25]  K. Bhatia,et al.  SPG7: The Great Imitator of MSA‐C Within the ILOCAs , 2018, Movement disorders clinical practice.

[26]  Jungsu S. Oh,et al.  Different loss of dopamine transporter according to subtype of multiple system atrophy , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  Reyes García-Eulate,et al.  Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process. , 2014, Brain : a journal of neurology.

[28]  Jungsu S. Oh,et al.  Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging , 2013, Nuclear Medicine and Molecular Imaging.

[29]  Y. Hashizume,et al.  Neuronal cell loss of the striatonigral system in multiple system atrophy , 1993, Journal of the Neurological Sciences.

[30]  Klaus Seppi,et al.  Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease. , 2005, Brain : a journal of neurology.

[31]  Z. Pirtošek,et al.  A case of multiple system atrophy with normal dopamine transporter imaging , 2012, Journal of Neurology.

[32]  Robert B. Innis,et al.  [123I]β‐CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy , 2001 .

[33]  L. Forsgren,et al.  The relation between cognition and motor dysfunction in drug‐naive newly diagnosed patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[34]  Ji Hyun Ko,et al.  Parkinson's disease cognitive network correlates with caudate dopamine , 2013, NeuroImage.

[35]  V. Dhawan,et al.  Changes in network activity with the progression of Parkinson's disease. , 2007, Brain : a journal of neurology.

[36]  M. Mishina,et al.  Presynaptic and postsynaptic nigrostriatal dopaminergic functions in multiple system atrophy , 2008, Neuroreport.